01515 CR MEDICAL
- 3.940
- +0.010+0.25%
CR MEDICAL News
China Resources Healthcare (01515.HK): Revenue fluctuates slightly in the short term, profit optimization is worth looking forward to
GF Securities: Maintains a "buy" rating for CR Medical (01515) with a fair value of 5.98 Hong Kong dollars.
Citigroup: rated cr medical(01515) as "buy" with target price of HKD 7.
China Resources Healthcare (01515.HK): Innovate operation and management, expand business integration with internal and external resources to increase performance
CICC: Maintaining China Resources Healthcare's (01515) “Outperform the Industry” Rating Target Price of HK$5.6
China Resources Healthcare (01515.HK): Performance is in line with expectations, gross margin increased year-on-year
China Resources Healthcare (01515.HK): Steady growth in hospital revenue and increasing profit contribution
Research Report Nuggets | CICC: First to give China Resources Healthcare a “Outperform the Industry” rating target price of HK$6.99
China Resources Healthcare (01515.HK): Building a New Development Model for State-owned Enterprises to Run Medical Leaders Around Discipline
China Resources Healthcare (01515.HK): Group Operation Management Enhances Endogenous Outbound Contribution Performance Increases
China Resources Healthcare (01515.HK): 23H1 Hospital resumes strong and shows advantages in group operation
China Resources Healthcare (01515.HK): Hospital operations are generally stable, and cash purchases have greatly increased performance
Major bank ratings | Credit Suisse: China Resources Healthcare (1515.HK) raised its target price to HK$6.8 to “neutral”
Changes in Hong Kong stocks | China Resources Healthcare rose more than 4%, institutions bullish target price to HK$9.46
China Resources Healthcare (1515.HK): The company may benefit from the recent fiscal interest rate discount policy
China Resources Healthcare (01515.HK): Performance is relatively stable, and the Group's hospital asset consolidation is yet to be timed
China Resources Healthcare (01515.HK): Steady growth in performance and full integration of China Resources Health
China Resources Healthcare (01515.HK): Steady operations and comprehensive comparative valuations of peers are attractive
China Resources Healthcare (01515.HK): Healthcare business revenue rebounds, investment and mergers and acquisitions continue to advance
China Resources Healthcare (01515.HK): Hospital business resumes endogenous+mergers and acquisitions expand hospital network
No Data
